ArticleTheranostics2024

Targeting DAD1 gene with CRISPR-Cas9 system transmucosally delivered by fluorinated polylysine nanoparticles for bladder cancer intravesical gene therapy.

Dongdong Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.